Salute e Benessere

The Latest Global Survey from ISAPS Reports a Rise in Aesthetic Surgery…

The report shows a 11.2% overall increase in procedures performed by plastic surgeons in 2022 with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. The report shows a 11.2% overall increase in procedures performed by plastic surgeons in 2022 with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Highlights The report shows a continuing rise in aesthetic surgery with a 41.3% increase over the last...
PR Newswire
01/09/2023

Information on the Total Number of Voting Rights (Denominator) following…

Regulated Information - Denominator Atlas Special Opportunities, LLChas converted 10convertible bonds in Oxurion resulting in a EUR 250 ,000capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion.Leuven, BELGIUM ,Boston, MA, US...
Nasdaq GlobeNewswire
01/09/2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – September 1 , 2023 – 7 .00PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on September 1,...
Nasdaq GlobeNewswire
01/09/2023

Progress share buy-back program Fagron

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 1 September 2023 – 6PM CET Progress share buy-back program Fagron In the period from 28 August 2023 through 1 September 2023, Fagron purchased 13,500 of its owns shares at an average price of €16.17 per share corresponding to a total amount of €218,323.35. These purchases are part of the share buy-back program of up to 138,372 Fagron shares to fulfill Fagron's obligations under its long term incentive scheme, which was...
Nasdaq GlobeNewswire
01/09/2023

Monthly Publication of the Number of Shares Composing the Share Capital and of…

Nicox SA Société anonyme with a registered capital of € 50,170,498 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On September 1, 2023, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlementgénéral of the l'AMF) As of August 31, 2023 Total number of...
Nasdaq GlobeNewswire
01/09/2023

Multimodal Imaging Market worth $5.5 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3358876 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3358876 Browse in-depth TOC on "Multimodal Imaging Market" 150 - Tables 40 - Figures 300 - Pages Multimodal Imaging Market Scope: Technology segment to register significant growth rate over the forecast period of 2023-2028 Based on technology, the global multimodal imaging...
PR Newswire
01/09/2023

Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market…

Key Takeaways Key Takeaways Anti-rheumatic Market is valued atUS$ 62.97 Billionin 2022 and it is expected to reachUS$ 76.13 Billionby 2029 with a CAGR of 2.75% over 2022-2029. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/2617 Elaborating The Key Trends and Dynamics of Anti-rheumatic Market Growing occurrence of auto-immune disorders, surge in the geriatric population base, and increased prevalence of orthopaedic conditions are the...
PR Newswire
01/09/2023

Xavi Hernandez unveils The Collectible memorabilia by Ultimate Dropz

Xavi's memorabilia, 'The Collectible', includes carefully curated 150 high-end boxes capturing El Maestro's significant moments withSpain'snational team, FC Barcelona andQatar'sAl-Sadd club. Designed by theGermany -based Ultimate Dropz, each box of the memorabilia opens a gateway for fans to immerse themselves in the nostalgia, relive the historic milestones of Barca, and deepen their connection with both Xavi and the club that holds a special place in their hearts...
PR Newswire
01/09/2023

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to…

BBS-Bioactive Bone Substitutes Plc, Company announcement, 1 September 2023 at 3:00 p.m.BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd BBS-Bioactive Bone Substitutes Plc (“BBS” or the "Company") has received a request by Riverfort Global Opportunities PCC Ltd to convert a proportion of EUR 75,000 of the convertible notes into Company shares at a conversion price of EUR 0...
Nasdaq GlobeNewswire
01/09/2023

Smartmi Launches Mist-Free Evaporative Humidifier 3 for Whole Home Hydration

Innovative Technology for Healthier Air Innovative Technology for Healthier Air Smartmi's evaporative system mimics natural humidity for air that feels fresh and inviting. With mist-free humidification technology, the evaporator evenly contacts the pure water in the water collector and then slowly rotates to form a large, ultra-thin water film. A strong cross-flow fan blows above the film, accelerating evaporation to provide natural humidity in a gentle way. Integrated air drying...
PR Newswire
01/09/2023

Report of transactions of shares and related securities of Bavarian Nordic by…

COPENHAGEN, Denmark, September 1, 2023– Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associated a)NameHenrik Juuel 2.Reason for the notification a)Position/statusExecutive Vice President...
Nasdaq GlobeNewswire
01/09/2023

Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

Dr. Kaufmann joins Hansa from Pieris Pharmaceuticals where he has served as Chief Scientific Officer since 2019. He led the company's R&D platform developing innovative next generation protein therapeutics leading to regulatory submissions across several indications. He played an integral role in transforming the company's operational excellence including accelerated development paths, machine-learning driven R&D and reliable high-performance manufacturing as well as delivery. Dr…
PR Newswire
01/09/2023

Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for…

Monday, 4 September 2023 at 14.00 – 15.00 CESTIn connection with the completion of the acquisition of Kerecis, Coloplast will host a conference call with Fertram Sigurjonsson, Founder and CEO of Kerecis. A presentation will be available on Coloplast's website before the conference call.The webcast of the conference call will be available during and after the event. Coloplast will be represented by :Kristian Villumsen- President & CEOAnders Lonning-Skovgaard- Executive Vice...
Nasdaq GlobeNewswire
01/09/2023

Leslie McDonnell joins Mölnlycke's Board of Directors

"I am pleased to welcome Leslie as a Member of the Mölnlycke Board," comments Karl-Henrik Sundström, Chairman of the Board. "Leslie is an accomplished and strategic healthcare executive with extensive experience in medical devices, disposables and supplies, and capital equipment. She is a builder and a transformer with a proven track record of driving profitable growth across portfolio life cycles and geographies that includes experience in wound care. She will be a great addition…
PR Newswire
01/09/2023

Zerion Pharma A/S appoints Mads Aaboe Jensen as Vice President, Business…

Mads Aaboe Jensen joins ZERION with more than 20 years of experience at the crossroads of science and business. Prior to joining ZERION, he was VP of Business Development and Innovation at Scandion Oncology A/S, and before that he was leading RNA molecule external innovation at Roche. He is an established life science innovator and holds a MSc degree in Molecular Biology and a PhD degree in Medicine from Aarhus University. Furthermore, he has completed an executive CBL management & business…
PR Newswire
01/09/2023

PCI Biotech: Write-down of share capital registered

Parts of the share capital reduction amount shall be used to cover loss that cannot be covered in any other way and the residual of the reduction amount shall be transferred to other equity.The capital reduction was registered in the Norwegian Register of Business Enterprises on 16 thAugust 2023, and the transaction has thus been completed.The share capital is now NOK 1,119,791.70, divided into 37,326,390 shares, each with a nominal value of NOK 0.03.Contact information: Ronny...
Nasdaq GlobeNewswire
01/09/2023

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 01092023_trading_in_shares_KV_ALS_and_RVP
Nasdaq GlobeNewswire
01/09/2023

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 01092023_trading_in_shares_Coloplast_Holding ApS_and_Gerda_Louis-Hansen
Nasdaq GlobeNewswire
01/09/2023

LG PRESENTS VISION FOR A SUSTAINABLE FUTURE WITH ENERGY-EFFICIENT TECHNOLOGIES…

Themed "How to Respond to Climate Change – LG Core-Techs for Sustainability," the tech briefing highlighted the importance of electrification; one of LG's key 'insights on trends' centering on the use of advanced core technologies to enhance energy efficiency. During the session, Peter Verkempynck, senior vice president of LG Air Solutions Europe B2B Sales, presented the cornerstone of LG's electrification strategy – the advancement of LG heat pump technology. Themed "How to…
PR Newswire
01/09/2023

Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL. Coloplast announces registration of share capital increase of 12.2 new B shares completedColoplast A/S (“Coloplast”) has in connection with the directed issue and private...
Nasdaq GlobeNewswire
01/09/2023

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

/V01 de 25/08/2023). This authorisation permits the Company to manufacture, import, and export medicinal cannabis products to numerous global markets and represents a significant step for the Company towards revenue generation. The Company also announces that it has successfully raised €5 million of new capital to fund its ambitious growth plans.This INFRAMED authorisation awards the Company a GMP Certificate Part I and Part II, enabling it to execute its plan to own distribution channels in...
Nasdaq GlobeNewswire
01/09/2023

Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by…

PARIS, FRANCE,1 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of Research and Development. She will succeed Howard Mayer, EVP and Head of R&D, who will leave Ipsen on September 22, following his decision to retire.Christelle Huguet will serve on the Executive Leadership Team (ELT), reporting directly to Ipsen's Chief Executive Officer,...
Nasdaq GlobeNewswire
01/09/2023

Neoss® Group welcomes Sandra von Schmudde as new Managing Director of Neoss GmbH

Sandra brings a wealth of academic and professional accomplishments to this role. Her educational background includes a degree in Business Administration with a specialization in European Management. Notably, her recent tenure as the Managing Director for the DACH region at Septodont GmbH showcases her adeptness in strategic leadership and management. Sandra brings a wealth of academic and professional accomplishments to this role. Her educational background includes a degree in Business...
PR Newswire
01/09/2023

BioSenic S.A. : Information on the total number of voting rights and shares

Information on the total number of voting rights and sharesMont-Saint-Guibert, Belgium, September 1, 2023 , 7 .00 am CEST –BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in in the areas of innate immunity, inflammation and organ/function repair, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares following the conversion of convertible bonds...
Nasdaq GlobeNewswire
01/09/2023
Altri  Comunicati